Related Experiment Video
Updated: Dec 4, 2025
09:09
High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
8.2K
The Pro-Differentiation Effect of Doxycycline on Human SZ95 Sebocytes
Christos C Zouboulis1, Síona Ní Raghallaigh2, Gerd Schmitz3
1Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany, christos.zouboulis@mhb-fontane.de.
Dermatology (Basel, Switzerland)
|October 22, 2020
Summary
Doxycycline reduces sebocyte cell numbers and increases lipid content, potentially by upregulating PPARγ. This finding offers new insights into treating acne and rosacea.
Area of Science:
- Dermatology
- Cell Biology
- Pharmacology
Background:
- Tetracyclines, including doxycycline, are widely used for acne vulgaris and rosacea.
- The impact of tetracyclines on sebocytes, key cells in sebaceous glands, remains largely unexplored.
- Sebaceous glands play a critical role in the pathogenesis of acne and potentially rosacea.
Purpose of the Study:
- To investigate the effects of doxycycline on sebocytes using an in vitro model.
- To assess doxycycline's impact on sebocyte proliferation, viability, and lipid production.
- To examine doxycycline's influence on the expression of peroxisome proliferator-activated receptors (PPARs) in sebocytes.
Main Methods:
- Utilized the immortalized SZ95 sebaceous gland cell line for in vitro experiments.
- Assessed changes in SZ95 sebocyte cell numbers and viability following doxycycline treatment.
- Quantified lipid content in sebocytes and measured mRNA levels of PPAR-α and PPAR-γ.
- Compared doxycycline's effects with troglitazone, a known PPAR-γ agonist.
Main Results:
- Doxycycline treatment for 2 days reduced SZ95 sebocyte cell number and increased intracellular lipid content.
- Doxycycline upregulated PPAR-γ mRNA expression at 12 and 24 hours.
- Troglitazone upregulated PPAR-γ mRNA expression more rapidly, at 6 hours.
- Neither doxycycline nor troglitazone significantly affected PPAR-α mRNA levels.
Conclusions:
- Doxycycline exerts previously unrecognized effects on sebocytes in vitro.
- The observed effects of doxycycline on sebocytes may involve the modulation of PPAR-γ signaling.
- These findings suggest a potential mechanism for doxycycline's therapeutic efficacy in pilosebaceous unit disorders like acne and rosacea.
